Proceedings: The change of fibrin split products and plasmin-inhibitor in the newborn infant.
D000991:Antithrombins / Q000032:analysis; D001238:Asphyxia Neonatorum / Q000097:blood; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D006801:Humans; D007231:Infant, Newborn; D010958:Plasminogen / Q000032:analysis; D012127:Respiratory Distress Syndrome, Newborn / Q000097:blood; D000515:alpha 1-Antitrypsin / Q000032:analysis; D000511:alpha-Macroglobulins / Q000032:analysis
D000991:Antithrombins; D005338:Fibrin Fibrinogen Degradation Products; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; D010958:Plasminogen; D005341:Fibrinolysin